Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone
✍ Scribed by Juha Grönlund; Teijo I. Saari; Nora M. Hagelberg; Pertti J. Neuvonen; Klaus T. Olkkola; Kari Laine
- Book ID
- 108642503
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 909 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0306-5251
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Dextromethorphan is used as a probe drug for assessing CYP2D6 and CYP3A4 activity __in vivo__ and __in vitro__. A SIM GC/MS method without derivatization for the simultaneous determination of dextromethorphan and its metabolites, dextrorphan, 3‐methoxymorphinan and 3‐hydroxymorphinan, i
In the early stage of drug discovery, thousands of new chemical entities (NCEs) may be screened before a single drug candidate can be identified for development. In order to accelerate the drug discovery process, we have developed higher-throughput enzyme assays to evaluate the inhibition of cytochr